We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKQ icon
1126
LKQ Corp
LKQ
$6.3B
$18.3M ﹤0.01%
576,930
+461,551
+400% +$15M
FCE.A
1127
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$18.2M ﹤0.01%
817,726
+1,048
+0.1% +$22.8K
COKE icon
1128
Coca-Cola Consolidated
COKE
$12.7B
$18.2M ﹤0.01%
1,234,140
+40,100
+3% +$586K
IFF icon
1129
International Flavors & Fragrances
IFF
$21.5B
$18.2M ﹤0.01%
144,002
-133,533
-48% -$16.5M
WU icon
1130
Western Union
WU
$2.34B
$18.1M ﹤0.01%
941,479
-1,232,723
-57% -$23.9M
THR
1131
DELISTED
Thermon Group Holdings
THR
$17.9M ﹤0.01%
932,264
+65,064
+8% +$1.25M
CAMP
1132
DELISTED
CalAmp Corp.
CAMP
$17.7M ﹤0.01%
52,027
-100
-0.2% -$35.1K
UTHR icon
1133
United Therapeutics
UTHR
$21.5B
$17.7M ﹤0.01%
166,806
-4,607
-3% -$514K
W icon
1134
Wayfair
W
$13.8B
$17.6M ﹤0.01%
451,787
-16,925
-4% -$675K
AFSI
1135
DELISTED
AmTrust Financial Services, Inc.
AFSI
$17.6M ﹤0.01%
719,088
+3,300
+0.5% +$84.1K
LNC icon
1136
Lincoln National
LNC
$8.63B
$17.5M ﹤0.01%
451,555
-20,900
-4% -$887K
GCP
1137
DELISTED
GCP Applied Technologies Inc.
GCP
$17.5M ﹤0.01%
671,069
+196,572
+41% +$4.61M
RRC icon
1138
Range Resources
RRC
$9.31B
$17.5M ﹤0.01%
404,910
-47,325
-10% -$1.94M
HAS icon
1139
Hasbro
HAS
$13.6B
$17.4M ﹤0.01%
207,633
-2,669
-1% -$226K
AEO icon
1140
American Eagle Outfitters
AEO
$2.72B
$17.4M ﹤0.01%
1,091,750
-311,710
-22% -$4.76M
CADE
1141
DELISTED
Cadence Bank
CADE
$17.3M ﹤0.01%
764,265
-24,690
-3% -$557K
AWI icon
1142
Armstrong World Industries
AWI
$7.72B
$17.2M ﹤0.01%
439,555
SFS
1143
DELISTED
Smart & Final Stores, Inc.
SFS
$17.2M ﹤0.01%
1,152,232
+4,372
+0.4% +$68.3K
SAVE
1144
DELISTED
Spirit Airlines, Inc.
SAVE
$17M ﹤0.01%
379,874
-7,541
-2% -$335K
IWM icon
1145
iShares Russell 2000 ETF
IWM
$82.5B
$17M ﹤0.01%
147,639
-110
-0.1% -$12.4K
USPH icon
1146
US Physical Therapy
USPH
$1.23B
$16.9M ﹤0.01%
281,330
+12,300
+5% +$674K
ARRS
1147
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$16.8M ﹤0.01%
803,306
+32,359
+4% +$734K
GIII icon
1148
G-III Apparel Group
GIII
$1.43B
$16.8M ﹤0.01%
366,534
-4,066
-1% -$175K
MOS icon
1149
The Mosaic Company
MOS
$6.84B
$16.6M ﹤0.01%
635,668
+49,200
+8% +$1.31M
JOE icon
1150
St. Joe Company
JOE
$3.9B
$16.6M ﹤0.01%
934,634
+345,201
+59% +$5.88M

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.